Aglaris is a company automating and controlling the cell culture processes. It develops stem cell technology for cell therapy, regenerative medicine, tissue engineering, and biomedical research. It provides Aglaris Facer 1.0, a fully-automated cell culture reactor that doesn’t use trypsin and enables users to obtain vast amounts of cells.